Biogen Pharmachem Industries Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 0.58 | 0.54 | -0.10 |
| Operating Expense | 0.94 | 0.08 | 0.39 |
| Net Profit | -0.36 | 0.46 | -0.49 |
| Net Profit Margin | -62.07% | 85.19% | 490.00% |
| Earning Per Share | 0 | 0.01 | -0.01 |
| EBIDTA | -0.36 | 0.46 | -0.49 |
| Effective Tax Rate | -0% | 0% | -0% |
Particulars
Mar 2026
Revenue0.58
Operating Expense0.94
Net Profit-0.36
Net Profit Margin-62.07
Earning Per Share0
EBIDTA-0.36
Effective Tax Rate-0
